United Therapeutics CEO Rothblatt Sells $5.1M in Stock as Company Accelerates Buyback Program
Martine Rothblatt, chairperson and chief executive officer of United Therapeutics Corporation (NASDAQ: UTHR), executed multiple stock sales on March 25, 2026, totaling roughly $5.1 million, and exercised options for 9,500 shares the same day. The trades were carried out under a 10b5-1 plan adopted in November 2025. The company has also announced a …